SRPT Sarepta Therapeutics Options Ahead of EarningsAnalyzing the options chain and the chart patterns of SRPT Sarepta Therapeuticsprior to the earnings report this week,
I would consider purchasing the 120usd strike price Calls with
an expiration date of 2025-8-15,
for a premium of approximately $9.30.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Sareptatherapeutics
SRPT Sarepta Therapeutics Potential Buyout SoonIf you haven`t bought SRPT here:
Then you need to know that there is a Massive catalyst coming!
Sarepta Therapeutics is going to announce Duchenne muscular dystrophy Phase 3 data for its SRP-9001-301 - (EMBARK) by mid November.
This week institutions bought calls worth more than $10Mil that SRPT Sarepta Therapeutics will trade above $135 by November 17.
Some even bought the $210 strike price!
They also have a big partnership with the giant Roche Holding AG (RHHBY).
I think SRPT Sarepta Therapeutics is well positioned for a potential takeover soon!
Looking forward to read your opinion about it.